Clinical trial
DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion. The DISCRETE CTO Study.
NCT02936011 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in Chronic Total Occlusion. The DISCRETE CTO Study.
- Lead sponsor
- Belfast Health and Social Care Trust
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- March 31, 2019
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.